683 Capital Management »

Spruce Biosciences shares owned by 683 Capital Management

Quarter-by-quarter ownership of Spruce Biosciences (SPRB) shares owned by 683 Capital Management from 13F filings

Historical chart of 683 Capital Management investment in Spruce Biosciences

Tip: Access up to 7 years of quarterly data

All positions including Spruce Biosciences held by 683 Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Spruce Biosciences by 683 Capital Management

Quarter filed Position value Share count Share price at filing
2024-06-30 $73k 141k 0.52

More positions owned by 683 Capital Management

Eli Lilly & Co. Put Option (LLY)
Tesla Motors Call Option (TSLA)
Capital One Financial (COF)
Hilton Grand Vacations (HGV)
Sharkninja Com Shs (SN)
Ero Copper Corp (ERO)
BorgWarner (BWA)
Carvana Cl A (CVNA)
Occidental Pete Corp *w Exp 08/03/202 (OXY.WS)
Moderna (MRNA)
Alnylam Pharmaceuticals Put Option (ALNY)
Wave Life Sciences SHS (WVE)
Tg Therapeutics (TGTX)
Bridgebio Pharma Note 2.500% 3/1 (Principal)
Insmed Note 0.750% 6/0 (Principal)

View all positions for 683 Capital Management

Top funds holding Spruce Biosciences

RiverVest Venture Management
Carlyle
Rock Springs Capital Management
Acadian Asset Management
Vanguard Group
Altium Capital Management
Almitas Capital
Renaissance Technologies
Geode Capital Management
Citadel Advisors
683 Capital Management
BlackRock
Bridgeway Capital Management
Superstring Capital Management
Lion Point Capital

View all funds holding Spruce Biosciences